Edwards Lifesciences (EW) Shares Outstanding (Diluted Average) (2009 - 2026)

Edwards Lifesciences' Shares Outstanding (Diluted Average) history runs 16 years deep, the most recent figure standing at $580.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 1.21% year-over-year to $580.7 million; the TTM figure through Mar 2026 stood at $580.7 million (down 1.21% YoY), while the FY2025 annual figure was $585.8 million, down 2.25% from the prior year.
• Shares Outstanding (Diluted Average) was $580.7 million for Q1 2026 at Edwards Lifesciences, down from $585.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $629.4 million in Q1 2022 to a low of $580.7 million in Q1 2026.
• Historically, Shares Outstanding (Diluted Average) has averaged $604.8 million across 5 years, with a median of $604.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) slipped 0.3% in 2022, then slipped 2.94% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $624.2 million in 2022, then slipped by 2.37% to $609.4 million in 2023, then declined by 1.66% to $599.3 million in 2024, then dropped by 2.25% to $585.8 million in 2025, then retreated by 0.87% to $580.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $580.7 million (Q1 2026), $585.8 million (Q4 2025), and $585.7 million (Q3 2025), per Business Quant data.